Literature DB >> 11952148

Skin allograft rejection is suppressed in mice lacking the antiviral enzyme, 2',5'-oligoadenylate-dependent RNase L.

Robert H Silverman1, Aimin Zhou, Michael B Auerbach, Danielle Kish, Anton Gorbachev, Robert L Fairchild.   

Abstract

The 2-5A/RNase L system is a regulated RNA decay pathway that mediates some of the antiviral and tumor suppressor activities of the interferons. Previously, we demonstrated that RNase L-null mice have increased susceptibility to viral infections and are partially deficient in induced and spontaneous apoptosis. To determine if RNase L functions in cellular, as well as innate, immunity, skin allograft rejection and contact hypersensitivity (CHS) experiments were performed in RNase L+/+ and RNase L-/- mice. Although no consistent alterations in CHS were found, we did observe a delay of 5 days in the acute rejection of class II major histocompatibility complex (MHC) disparate skin allografts in mice lacking RNase L. Accordingly, histologic examinations of the allografts harvested from RNase L-/- mice revealed a dramatic reduction in inflammatory infiltrates, suggesting a delay in T-cell priming or a deficiency in immune cell trafficking. Results consistent with a proinflammatory role for RNase L extend the known functions of the 2-5A/RNase L system beyond innate immunity into some, but not all, types of cellular immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952148     DOI: 10.1089/088282402317340242

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  10 in total

Review 1.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

2.  Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase L.

Authors:  Rebecca J Duerst; Lynda A Morrison
Journal:  Virology       Date:  2006-12-06       Impact factor: 3.616

3.  RNase L contributes to experimentally induced type 1 diabetes onset in mice.

Authors:  Chun Zeng; Xin Yi; Danny Zipris; Hongli Liu; Lin Zhang; Qiaoyun Zheng; Krishnamurthy Malathi; Ge Jin; Aimin Zhou
Journal:  J Endocrinol       Date:  2014-10-06       Impact factor: 4.286

4.  RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer.

Authors:  Tiha M Long; Arindam Chakrabarti; Heather J Ezelle; Sarah E Brennan-Laun; Jean-Pierre Raufman; Irina Polyakova; Robert H Silverman; Bret A Hassel
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

Review 5.  Pathologic effects of RNase-L dysregulation in immunity and proliferative control.

Authors:  Heather J Ezelle; Bret A Hassel
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

6.  RNase L Is Involved in Liposaccharide-Induced Lung Inflammation.

Authors:  Ruhan Wei; Guanmin Chen; Naseh Algehainy; Chun Zeng; Chunfang Liu; Hongli Liu; Wendy Liu; Dennis Stacey; Aimin Zhou
Journal:  Viruses       Date:  2020-01-07       Impact factor: 5.048

7.  RNase L mediated protection from virus induced demyelination.

Authors:  Derek D C Ireland; Stephen A Stohlman; David R Hinton; Parul Kapil; Robert H Silverman; Roscoe A Atkinson; Cornelia C Bergmann
Journal:  PLoS Pathog       Date:  2009-10-02       Impact factor: 6.823

Review 8.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

9.  Lack of RNase L attenuates macrophage functions.

Authors:  Xin Yi; Chun Zeng; Hongli Liu; Xiaoli Chen; Ping Zhang; Boo Seok Yun; Ge Jin; Aimin Zhou
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

Review 10.  The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response.

Authors:  Heather J Ezelle; Krishnamurthy Malathi; Bret A Hassel
Journal:  Int J Mol Sci       Date:  2016-01-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.